Starbucks Corporation (SBUX) is Polen Capital Management LLC's 8th Largest Position

Lloyd Doyle
November 15, 2017

Nomura dropped their price objective on Starbucks Corporation from $67.00 to $63.00 and set a "buy" rating for the company in a research note on Friday, November 3rd. The SI to Immucell Corporation's float is 0.36%. About 1.53 million shares traded. It has underperformed by 58.40% the S&P500.

Daiwa Sb Investments Ltd decreased Starbucks Corp (SBUX) stake by 90.29% reported in 2017Q2 SEC filing. Adi Capital Management Llc sold 32,000 shares as Symantec Corp (SYMC)'s stock rose 0.76%. The value of the investment in Starbucks Corp went from $88,631,000 to $48,070,000 decreasing 45.8% since the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Starbucks Corporation by 5.2% during the 2nd quarter. Pension Ser owns 1.17M shares.

More notable recent Starbucks Corporation (NASDAQ:SBUX) news were published by: which released: "Starbucks: India A Top 5 Market?" on November 07, 2017, also with their article: "Starbucks: Rating Update" published on November 14, 2017, published: "Starbucks: What I Like About Its Q4 Earnings Report" on November 06, 2017. It has underperformed by 4.22% the S&P500. Therefore 71% are positive.

Starbucks Corporation purchases and roasts high-quality whole bean coffees and sells them along with fresh, rich-brewed, Italian style espresso beverages, a variety of pastries and confections, and coffee-related equipments primarily through its company-operated retail stores. The stock now has a consensus rating of "Buy" and an average target price of $63.31. Cowen & Co maintained Starbucks Corporation (NASDAQ:SBUX) rating on Friday, July 28. Scotia Capital downgraded the shares of CX in report on Wednesday, April 6 to "Sector Perform" rating. The stock of Starbucks Corporation (NASDAQ:SBUX) has "Hold" rating given on Friday, July 28 by Guggenheim. Jefferies maintained it with "Buy" rating and $65.0 target in Tuesday, August 22 report. On Friday, November 3 the stock rating was maintained by Robert W. Baird with "Outperform". The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has "Hold" rating given on Friday, January 6 by Maxim Group. The stock of Starbucks Corporation (NASDAQ:SBUX) earned "Outperform" rating by BMO Capital Markets on Friday, July 28. The firm has "Outperform" rating given on Monday, March 13 by Wedbush. On Friday, August 28 the stock rating was downgraded by Vetr to "Strong-Buy".

The company's stock is now moving with a -ve distance from the 200 day SMA of approximately -0.9%, and has a solid year to date (YTD) performance of 2.02% which means that the stock is constantly adding to its value from the previous fiscal year end price. Its up 0.34, from 0.87 in 2017Q1. It increased, as 68 investors sold Starbucks Corporation shares while 409 reduced holdings.

Several institutional investors and hedge funds have recently made changes to their positions in the stock. In the latest earnings report the EPS was $1.97 with 1.43B shares now outstanding. Perhaps, that suggests something about why 74.72% of the outstanding share supply is held by institutional investors. Moreover, Regions Finance Corporation has 0.33% invested in Starbucks Corporation (NASDAQ:SBUX). The shares were sold at an average price of $57.61, for a total transaction of $3,627,471.26. Nexus Inv Mgmt Inc owns 24,000 shares or 0.23% of their United States portfolio. After $0.95 actual EPS reported by Teva Pharmaceutical Industries Ltd (ADR) for the previous quarter, Wall Street now forecasts -5.26% negative EPS growth. 32,694 are owned by Culbertson A N &. 0 analysts recommended Overweight these shares while 1 recommended Underweight, according to FactSet data. Korea Investment, a Korea-based fund reported 930,644 shares. Finally, Magellan Asset Management Ltd raised its stake in Starbucks Corporation by 3,809,645.9% during the first quarter. Arrowgrass Cap Partners (Us) Limited Partnership invested in 272,725 shares. Motco reported 73,125 shares.

Shares of Starbucks Corporation (SBUX) traded down $0.40 during trading on Thursday, hitting $56.64. Moreover, Grisanti Management Ltd Liability Corp has 2.42% invested in Starbucks Corporation (NASDAQ:SBUX).

Since May 18, 2017, it had 0 insider buys, and 2 selling transactions for $1.24 million activity. 114,826 shares were sold by BURROWS CLIFFORD, worth $6.83M on Thursday, May 18. 10,000 shares were sold by ULLMAN MYRON E III, worth $606,300 on Wednesday, June 14.

Investors sentiment increased to 2 in 2017 Q2. Its down 0.10, from 1.25 in 2017Q1. As of the end of the quarter Amf Pensionsforsakring Ab had sold 19,870 shares trimming its holdings by 1.5%.

Montag & Caldwell Llc, which manages about $14.22 billion and $3.39 billion US Long portfolio, decreased its stake in Mastercard Inc (NYSE:MA) by 64,719 shares to 656,902 shares, valued at $79.78M in 2017Q2, according to the filing. Sands Capital Mgmt reported 12.89 million shares or 2.26% of all its holdings. Essex Fincl Services reported 23,776 shares. (NASDAQ:AMGN). Fayez Sarofim has invested 0.03% in Amgen, Inc. Sigma Counselors stated it has 6,894 shares or 0.06% of all its holdings. Wells Fargo Mn has invested 0% in ImmuCell Corporation (NASDAQ:ICCC).

In other Starbucks Corporation news, Director Javier G. Teruel sold 62,966 shares of the firm's stock in a transaction on Wednesday, November 8th. Destination Wealth Management owns 1,181 shares. Moreover, Commercial Bank Of America Corporation De has 0% invested in ImmuCell Corporation (NASDAQ:ICCC).

Other reports by Iphone Fresh

Discuss This Article